Esperion Therapeutics, Inc. (ESPR)

Esperion Therapeutics Statistics

Total Valuation

ESPR has a market cap or net worth of $158.34 million. The enterprise value is $637.71 million.

Market Cap	158.34M
Enterprise Value	637.71M

Important Dates

The last earnings date was Tuesday, May 6, 2025, before market open.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

ESPR has 198.20 million shares outstanding. The number of shares has increased by 54.12% in one year.

Current Share Class	198.20M
Shares Outstanding	198.20M
Shares Change (YoY)	+54.12%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	0.78%
Owned by Institutions (%)	58.16%
Float	196.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.60
Forward PS	0.41
PB Ratio	-0.37
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.46
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.18

Current Ratio	1.18
Quick Ratio	0.72
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.62

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-7.17%
Return on Invested Capital (ROIC)	-11.83%
Return on Capital Employed (ROCE)	-75.31%
Revenue Per Employee	$853,862
Profits Per Employee	-$504,020
Employee Count	304
Asset Turnover	0.74
Inventory Turnover	1.57

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -63.52% in the last 52 weeks. The beta is 0.75, so ESPR's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	-63.52%
50-Day Moving Average	1.26
200-Day Moving Average	1.89
Relative Strength Index (RSI)	32.42
Average Volume (20 Days)	5,700,443

Short Selling Information

The latest short interest is 29.86 million, so 15.07% of the outstanding shares have been sold short.

Short Interest	29.86M
Short Previous Month	30.03M
Short % of Shares Out	15.07%
Short % of Float	15.19%
Short Ratio (days to cover)	5.19

Income Statement

In the last 12 months, ESPR had revenue of $259.57 million and -$153.22 million in losses. Loss per share was -$0.81.

Revenue	259.57M
Gross Profit	124.12M
Operating Income	-39.96M
Pretax Income	n/a
Net Income	-153.22M
EBITDA	-39.92M
EBIT	-39.96M
Loss Per Share	-$0.81

Balance Sheet

The company has $114.63 million in cash and $594.00 million in debt, giving a net cash position of -$479.37 million or -$2.42 per share.

Cash & Cash Equivalents	114.63M
Total Debt	594.00M
Net Cash	-479.37M
Net Cash Per Share	-$2.42
Equity (Book Value)	-426.21M
Book Value Per Share	-2.17
Working Capital	47.81M

Cash Flow

In the last 12 months, operating cash flow was -$100.11 million and capital expenditures -$244,000, giving a free cash flow of -$100.35 million.

Operating Cash Flow	-100.11M
Capital Expenditures	-244,000
Free Cash Flow	-100.35M
FCF Per Share	-$0.51

Margins

Gross margin is 47.82%, with operating and profit margins of -15.40% and -59.03%.

Gross Margin	47.82%
Operating Margin	-15.40%
Pretax Margin	-59.03%
Profit Margin	-59.03%
EBITDA Margin	-15.38%
EBIT Margin	-15.40%
FCF Margin	n/a

Dividends & Yields

ESPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.12%
Shareholder Yield	-54.12%
Earnings Yield	-96.77%
FCF Yield	-63.38%

Analyst Forecast

The average price target for ESPR is $5.93, which is 642.27% higher than the current price. The consensus rating is "Buy".

Price Target	$5.93
Price Target Difference	642.27%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	28.03%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ESPR has an Altman Z-Score of -6.19 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.19
Piotroski F-Score	3